Greg Pyszczymuka insider trades

Open-market stock purchases and sales by Greg Pyszczymuka, Chief Commercial Officer at Aytu Biopharma, Inc, from SEC Form 4 filings since Dec 19, 2022.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +6%.

Recent trades

DateStockTradeValue
Jul 28, 2026AYTU Aytu Biopharma, IncBought (not open market)—
Dec 17, 2025EVOK Evoke Pharma IncSold (not open market)$30.7K
Dec 17, 2025EVOK Evoke Pharma IncSold (not open market)$4K

Companies traded

  • AYTU Aytu Biopharma, Inc: 2 buys, last Jul 28, 2026
  • EVOK Evoke Pharma Inc: other filings, last Dec 17, 2025

Get free alerts when Greg Pyszczymuka files a new trade →